| Priligy (dapoxetine) / AbbVie |
NCT00211094: A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation |
|
|
| Completed | 3 | 1320 | US | Dapoxetine | Alza Corporation, DE, USA | Ejaculation | | 06/04 | | |
NCT00211107: A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation. |
|
|
| Completed | 3 | 1294 | US | Dapoxetine | Alza Corporation, DE, USA | Ejaculation | | 06/04 | | |
NCT01230762: An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation |
|
|
| Completed | 3 | 1774 | US | dapoxetine | Alza Corporation, DE, USA | Ejaculation, Erectile Dysfunction, Sexual Dysfunction | | 04/05 | | |
NCT00210613: A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation |
|
|
| Completed | 3 | 199 | US | Dapoxetine | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Sexual Dysfunction, Ejaculation | | 08/05 | | |
NCT00210704: A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation |
|
|
| Completed | 3 | 1067 | US | Dapoxetine | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Erectile Dysfunction | | 06/06 | | |
NCT00229073: A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation |
|
|
| Completed | 3 | 1116 | US | dapoxetine | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Erectile Dysfunction | | 10/06 | | |
2004-002700-16: A Placebo-Controlled, Double-Blind, Randomized, Parallel-Group Study of the Efficacy and Safety of Dapoxetine in the Treatment of Subjects With Premature Ejaculation |
|
|
| Completed | 3 | 1300 | RoW, Europe | dapoxetine, R096769, NA, Tablet | Janssen-Cilag International N.V., JANSSEN-CILAG | Premature Ejaculation (PE) | | | | |
NCT01063881: The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy |
|
|
| Completed | 3 | 285 | RoW | Dapoxetine | Janssen Research & Development, LLC | Sexual Dysfunction, Physiological | 06/11 | 06/11 | | |
| Completed | 3 | 495 | US, Canada, Europe, RoW | Placebo, Dapoxetine, PDE5I (phosphodiesterase-5 inhibitor) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Erectile Dysfunction, Sexual Dysfunction | 08/11 | 09/11 | | |
NCT04085354: Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature Ejaculation |
|
|
| Completed | 3 | 120 | RoW | Multi-Vitamin Tablets, Dapoxetine, Dapoxetine and folic acid., Dapoxetine and vitamin B12 | Sohag University | Premature Ejaculation | 06/19 | 08/19 | | |
PE, NCT04703127: Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone. |
|
|
| Recruiting | 3 | 60 | RoW | Tadalafil and Combined Dapoxietine, Tadalafil with Combined Dapoxietine, Dapoxietine and Combined Lidocaine 5% Spray, Dapoxietine With Lidocaine 5% Spray | Sohag University | Premature Ejaculation | 01/21 | 01/21 | | |
| Recruiting | 3 | 129 | RoW | Tens therapy, Dapoxetine placebo, Standard treatment (dapoxetine 30 mg as needed), Placebo therapy | Boston Medical Group | Premature Ejaculation, Sex Disorder, TEN | 06/25 | 06/25 | | |
NCT07081659: On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation |
|
|
| Completed | 2/3 | 95 | RoW | sildosin 4mg, dapoxetine 60mg | Benha University | Premature (Early) Ejaculation | 03/24 | 04/25 | | |
